Assetmark Inc. Has $191,000 Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Assetmark Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,284 shares of the biopharmaceutical company’s stock after selling 193 shares during the quarter. Assetmark Inc.’s holdings in Intra-Cellular Therapies […]
Assetmark Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,284 shares of the biopharmaceutical company’s stock after selling 193 shares during the quarter. Assetmark Inc.’s holdings in Intra-Cellular Therapies […]
